Leadership Overview
Ipca Laboratories has 10 executives leading key functions including information technology, international marketing, manufacturing, domestic marketing, generics, medical affairs, corporate quality, research and development, and general management.
Committed to global health standards, Ipca Laboratories delivers high-quality pharmaceutical formulations and active pharmaceutical ingredients to diverse markets while maintaining rigorous manufacturing excellence and therapeutic innovation.
Committed to global health standards, Ipca Laboratories delivers high-quality pharmaceutical formulations and active pharmaceutical ingredients to diverse markets while maintaining rigorous manufacturing excellence and therapeutic innovation.
Leadership Roles at Ipca Laboratories
Shashil Mendonsa - President, International Marketing
Shashil Mendonsa, the President, International Marketing at Ipca Laboratories, executes the global expansion strategy for the company's extensive portfolio of formulations and active pharmaceutical ingredients. Overseeing market penetration across diverse geographic regions, the President, International Marketing ensures that therapeutic products reach healthcare providers and patients in emerging and established markets alike. This leadership role involves navigating complex international regulatory landscapes and building strategic partnerships to increase market share. By analyzing regional demand patterns, Shashil Mendonsa directly impacts the company's revenue growth and brand positioning on a global scale. Furthermore, Mendonsa coordinates with local distribution networks to maintain consistent supply chain reliability, ensuring that international operations remain responsive to shifting healthcare needs. Through the development of targeted promotional campaigns, the President, International Marketing strengthens the company's reputation as a trusted provider of high-quality, affordable medicine, ultimately securing long-term commercial success in competitive international territories.
Shailesh Laul - President, Manufacturing Operations
Shailesh Laul, the President, Manufacturing Operations at Ipca Laboratories, directs the production of over 350 formulations and 80 active pharmaceutical ingredients across multiple manufacturing sites. Overseeing the entire production lifecycle, the President, Manufacturing Operations ensures that all facilities adhere to stringent quality control protocols and international manufacturing standards. This leadership role involves optimizing plant capacity and streamlining workflows to maximize output while minimizing operational costs. By integrating advanced automation technologies into the production process, Shailesh Laul directly impacts the efficiency and scalability of the company's manufacturing capabilities. Furthermore, Laul manages the workforce and resource allocation to meet fluctuating global demand, ensuring that production schedules remain aligned with market requirements. Through the continuous improvement of manufacturing processes, the President, Manufacturing Operations maintains the high quality of pharmaceutical products, ultimately supporting the company's commitment to delivering reliable and effective healthcare solutions to patients worldwide.
Sunil Ghai - President, Marketing
Sunil Ghai, the President, Marketing at Ipca Laboratories, directs the domestic commercial strategy and brand management for the company's diverse therapeutic segments. Overseeing the sales force and promotional activities, the President, Marketing ensures that healthcare professionals receive accurate information regarding the company's extensive range of formulations. This leadership role involves identifying market opportunities and tailoring product messaging to address specific therapeutic needs within the domestic market. By analyzing competitive trends and consumer behavior, Sunil Ghai directly impacts the company's market share and brand loyalty. Furthermore, Ghai collaborates with the research and development teams to align product launches with current medical requirements, ensuring that the marketing strategy remains grounded in clinical relevance. Through the implementation of data-driven sales initiatives, the President, Marketing drives revenue growth and strengthens the company's presence in the pharmaceutical sector, ultimately ensuring that patients have consistent access to essential medications.
Kavita Sehwani - President - Generics
Kavita Sehwani, the President - Generics at Ipca Laboratories, directs the development and commercialization of the company's generic pharmaceutical portfolio. Overseeing the lifecycle management of generic products, the President - Generics ensures that these essential medications meet all regulatory requirements while remaining cost-effective for healthcare systems. This leadership role involves identifying high-potential generic opportunities and managing the transition from development to market launch. By optimizing the generic product pipeline, Kavita Sehwani directly impacts the company's ability to provide affordable healthcare alternatives to a broad patient base. Furthermore, Sehwani coordinates with regulatory affairs and manufacturing teams to ensure timely product approvals and consistent supply chain availability. Through the strategic expansion of the generic portfolio, the President - Generics strengthens the company's competitive position in the global market, ultimately supporting the mission of increasing access to high-quality, affordable pharmaceutical treatments for diverse populations.

Anil Pareek - President, Medical Affairs & Clinical Research
Anil Pareek, the President, Medical Affairs & Clinical Research at Ipca Laboratories, directs the clinical validation and medical strategy for the company's pharmaceutical pipeline. Overseeing the design and execution of clinical trials, the President, Medical Affairs & Clinical Research ensures that all research activities comply with ethical standards and regulatory guidelines. This leadership role involves bridging the gap between scientific research and clinical practice by providing medical expertise to support product development and marketing efforts. By managing relationships with key opinion leaders and medical institutions, Anil Pareek directly impacts the scientific credibility and therapeutic efficacy of the company's offerings. Furthermore, Pareek oversees the pharmacovigilance programs to monitor product safety and ensure patient well-being. Through the rigorous evaluation of clinical data, the President, Medical Affairs & Clinical Research validates the therapeutic value of new formulations, ultimately ensuring that the company's products meet the highest standards of medical excellence.
Saidutta Nanda - President
Saidutta Nanda, the President at Ipca Laboratories, directs the strategic oversight of specific business units to ensure alignment with the company's long-term growth objectives. Overseeing cross-functional initiatives, the President ensures that operational goals are met through effective resource management and interdepartmental collaboration. This leadership role involves evaluating market performance and adjusting business strategies to maintain a competitive edge in the pharmaceutical industry. By fostering a culture of innovation and accountability, Saidutta Nanda directly impacts the overall organizational performance and operational efficiency. Furthermore, Nanda works closely with other executive leaders to integrate new technologies and processes into the company's existing framework. Through the implementation of strategic business plans, the President drives sustainable growth and enhances the company's market position, ultimately ensuring that the organization remains a leader in the manufacturing and marketing of high-quality pharmaceutical formulations and active ingredients.
Sanjay Kapadia - President, Corporate Quality
Sanjay Kapadia, the President, Corporate Quality at Ipca Laboratories, directs the quality assurance and regulatory compliance framework across all manufacturing and research facilities. Overseeing the implementation of global quality standards, the President, Corporate Quality ensures that every product meets the highest safety and efficacy benchmarks before reaching the market. This leadership role involves conducting rigorous audits and maintaining compliance with international health authorities to uphold the company's reputation for excellence. By establishing robust quality management systems, Sanjay Kapadia directly impacts the reliability and consistency of the company's pharmaceutical output. Furthermore, Kapadia manages the training and development of quality control personnel to ensure a culture of continuous improvement and adherence to best practices. Through the proactive identification and mitigation of quality risks, the President, Corporate Quality safeguards the company's operations, ultimately ensuring that patients receive safe and effective medications that meet global regulatory requirements.

Murali Sarma - President
Murali Sarma, the President at Ipca Laboratories, directs the operational management of key business segments to drive efficiency and market expansion. Overseeing the execution of corporate strategy, the President ensures that all departments operate in harmony to achieve the company's mission of providing high-quality pharmaceutical products. This leadership role involves analyzing operational metrics and implementing improvements to optimize performance across the organization. By coordinating with various functional heads, Murali Sarma directly impacts the company's ability to respond to market demands and maintain a competitive advantage. Furthermore, Sarma focuses on scaling operations to support the company's growth in both domestic and international markets. Through the effective management of organizational resources and the promotion of strategic initiatives, the President supports the company's long-term success, ultimately ensuring that the organization continues to deliver value to stakeholders and patients through its integrated pharmaceutical business model.
Hitesh Maheshwari - President, Research & Development (Formulations)
Hitesh Maheshwari, the President, Research & Development (Formulations) at Ipca Laboratories, directs the innovation and development of new pharmaceutical formulations to expand the company's therapeutic portfolio. Overseeing the research laboratories and formulation scientists, the President, Research & Development (Formulations) ensures that the development pipeline remains robust and aligned with current medical needs. This leadership role involves managing the transition of new products from the laboratory stage to commercial production. By leveraging advanced scientific techniques and formulation technologies, Hitesh Maheshwari directly impacts the company's ability to introduce innovative and effective treatments to the market. Furthermore, Maheshwari collaborates with regulatory and clinical teams to ensure that all new formulations meet safety and efficacy standards. Through the continuous pursuit of scientific excellence, the President, Research & Development (Formulations) drives the company's growth, ultimately ensuring that the organization remains at the forefront of pharmaceutical innovation and patient care.
Ashok Nayak - Chief Information Officer
Ashok Nayak, the Chief Information Officer at Ipca Laboratories, directs the digital transformation and technological infrastructure supporting the company's pharmaceutical manufacturing operations. Overseeing enterprise-wide data security and systems integration, the Chief Information Officer ensures that all digital platforms align with global regulatory compliance standards. This leadership role involves architecting scalable cloud solutions to optimize supply chain visibility and production efficiency across international facilities. By implementing advanced analytics, Ashok Nayak directly impacts the speed and accuracy of pharmaceutical distribution. Furthermore, Nayak manages the cybersecurity framework protecting proprietary research data, ensuring that the technological backbone of the organization remains resilient against emerging threats. Through the modernization of internal communication networks, the Chief Information Officer facilitates seamless collaboration between research teams and manufacturing units, ultimately driving operational excellence and supporting the company's mission to provide accessible healthcare solutions worldwide.
Explore Leadership Teams in Manufacturing
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership AN
IG
AS
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
RW
SK
MA
Ascend Wellness Holdings is an American cannabis company specializing in the cultivation, processing, manufacturing, distribution, and retail sale of cannabis products. The company operates as a vertically integrated multi-state operator, managing different stages of the cannabis supply chain through cultivation facilities, manufacturing operations, branded product development, wholesale distribution, and retail dispensaries. Its business is focused on serving adult-use and medical cannabis markets in states where cannabis sales are permitted under applicable state regulations. The company aims to provide consumers with a consistent selection of cannabis products through its integrated production and retail network.
Company Leadership SB


MM
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership GO
MÇ
CK